Richard A. Anderson

36.4k total citations · 7 hit papers
437 papers, 24.9k citations indexed

About

Richard A. Anderson is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Richard A. Anderson has authored 437 papers receiving a total of 24.9k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Reproductive Medicine, 183 papers in Public Health, Environmental and Occupational Health and 151 papers in Molecular Biology. Recurrent topics in Richard A. Anderson's work include Reproductive Biology and Fertility (170 papers), Ovarian function and disorders (141 papers) and Sperm and Testicular Function (55 papers). Richard A. Anderson is often cited by papers focused on Reproductive Biology and Fertility (170 papers), Ovarian function and disorders (141 papers) and Sperm and Testicular Function (55 papers). Richard A. Anderson collaborates with scholars based in United Kingdom, United States and Australia. Richard A. Anderson's co-authors include William H. Wallace, Tom Kelsey, Scott M. Nelson, Evelyn E. Telfer, Jyothis T. George, Marilyn M. Polansky, David T. Baird, Norah Spears, D. Stewart Irvine and David Cameron and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Richard A. Anderson

425 papers receiving 24.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ESHRE Guideline: management of women with premature ovarian insufficiency

2016 996 citations Lisa Webber, Melanie Davies et al. Human Reproduction profile →
The physiology and clinical utility of anti-Müllerian hormone in women

2014 704 citations Scott M. Nelson, William H. Wallace et al. Human Reproduction Update profile →
Fertility preservation for young patients with cancer: who is at risk and what can be offered?

2005 583 citations William H. Wallace, Richard A. Anderson et al. profile →
ESHRE guideline: female fertility preservation†

2020 406 citations Richard A. Anderson, Isabelle Demeestere et al. profile →
A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause

2011 335 citations Scott M. Nelson, Richard A. Anderson et al. profile →
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†

2020 281 citations Matteo Lambertini, Fedro A. Peccatori et al. profile →
Making a good egg: human oocyte health, aging, and in vitro development

2023 86 citations Evelyn E. Telfer, Roseanne Rosario et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard A. Anderson United Kingdom	85	11.8k	11.1k	7.2k	3.6k	3.0k	437	24.9k
Frank H. de Jong Netherlands	85	10.7k 0.9×	8.7k 0.8×	5.1k 0.7×	8.6k 2.4×	4.3k 1.5×	451	26.2k
Anders Juul Denmark	90	8.8k 0.8×	5.0k 0.4×	8.3k 1.2×	9.5k 2.7×	5.6k 1.9×	655	29.8k
Aleksander Giwercman Sweden	73	10.5k 0.9×	5.3k 0.5×	5.4k 0.7×	4.3k 1.2×	2.7k 0.9×	375	22.9k
Frank Z. Stanczyk United States	86	4.7k 0.4×	5.8k 0.5×	4.2k 0.6×	8.1k 2.3×	6.5k 2.2×	602	25.2k
Henry Burger Australia	87	7.6k 0.6×	5.8k 0.5×	6.1k 0.9×	10.5k 3.0×	4.7k 1.6×	504	25.4k
Christina Wang United States	67	7.0k 0.6×	3.8k 0.3×	4.3k 0.6×	8.0k 2.2×	1.7k 0.6×	301	17.9k
Rakesh Sharma United States	77	15.0k 1.3×	11.5k 1.0×	2.6k 0.4×	1.0k 0.3×	1.7k 0.6×	388	20.9k
Sudhansu K. Dey United States	95	9.2k 0.8×	7.1k 0.6×	8.4k 1.2×	1.1k 0.3×	5.8k 2.0×	329	32.1k
Ricardo Azziz United States	82	22.3k 1.9×	14.1k 1.3×	6.0k 0.8×	8.3k 2.3×	2.2k 0.8×	389	30.6k
Richard S. Legro United States	79	23.8k 2.0×	16.1k 1.5×	3.1k 0.4×	6.0k 1.7×	1.7k 0.6×	385	30.3k

Countries citing papers authored by Richard A. Anderson

Since Specialization

Citations

This map shows the geographic impact of Richard A. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard A. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard A. Anderson more than expected).

Fields of papers citing papers by Richard A. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard A. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard A. Anderson. The network helps show where Richard A. Anderson may publish in the future.

Co-authorship network of co-authors of Richard A. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard A. Anderson. A scholar is included among the top collaborators of Richard A. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard A. Anderson. Richard A. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lambertini, Matteo, Deirdre Allegranza, Ruediger P. Laubender, et al.. (2025). Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients. JNCI Journal of the National Cancer Institute. 117(11). 2317–2326.

Jayasena, Channa, Katie E. Barber, Alexander Comninos, et al.. (2024). Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clinical Endocrinology. 101(5). 409–442. 11 indexed citations

Panay, Nick, Richard A. Anderson, Marcelle I. Cedars, et al.. (2024). Evidence-based guideline: Premature Ovarian Insufficiency. Fertility and Sterility. 123(2). 221–236. 16 indexed citations

Anderson, Richard A. & John Joseph Reynolds-Wright. (2024). The road to hormonal male contraception: End in sight?. Best Practice & Research Clinical Obstetrics & Gynaecology. 97. 102559–102559. 1 indexed citations

Hickey, Martha, Digsu N. Koye, Sabine Braat, et al.. (2024). Eggsurance? A randomized controlled trial of a decision aid for elective egg freezing. Human Reproduction. 39(8). 1724–1734. 3 indexed citations

Rosario, Roseanne, et al.. (2023). Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro. Human Reproduction. 39(2). 382–392. 19 indexed citations

Anderson, Richard A., David Cameron, Florian Clatot, et al.. (2022). Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Human Reproduction Update. 28(3). 417–434. 61 indexed citations

Anderson, Richard A., et al.. (2021). miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia. Blood. 138(21). 2066–2092. 24 indexed citations

Rosario, Roseanne & Richard A. Anderson. (2020). The molecular mechanisms that underlie fragile X-associated premature ovarian insufficiency: is it RNA or protein based?. Molecular Human Reproduction. 26(10). 727–737. 11 indexed citations

10.

Pervolaraki, Eleftheria, James Dachtler, Richard A. Anderson, & Arun V. Holden. (2017). Ventricular myocardium development and the role of connexins in the human fetal heart. Scientific Reports. 7(1). 12272–12272. 20 indexed citations

11.

Webber, Lisa, Melanie Davies, Richard A. Anderson, et al.. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. 31(5). 926–937. 996 indexed citations breakdown →

12.

Kilcoyne, Karen, Lee B. Smith, Nina Atanassova, et al.. (2014). Fetal programming of adult Leydig cell function by androgenic effects on stem/progenitor cells. Proceedings of the National Academy of Sciences. 111(18). E1924–32. 149 indexed citations

13.

Brougham, Mark, Patricia M. Crofton, Emma Johnson, et al.. (2012). Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study. The Journal of Clinical Endocrinology & Metabolism. 97(6). 2059–2067. 149 indexed citations

14.

Ivanovs, Andrejs, Stanislav Rybtsov, Lindsey Welch, et al.. (2011). Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. The Journal of Experimental Medicine. 208(12). 2417–2427. 187 indexed citations

15.

Wylie, Kevan, Margaret Rees, Geoff Hackett, et al.. (2010). Androgens, health and sexuality in women and men. Maturitas. 67(3). 275–289. 44 indexed citations

16.

Liu, Peter Y., Ronald S. Swerdloff, Bradley D. Anawalt, et al.. (2008). Determinants of the Rate and Extent of Spermatogenic Suppression during Hormonal Male Contraception: An Integrated Analysis. The Journal of Clinical Endocrinology & Metabolism. 93(5). 1774–1783. 86 indexed citations

17.

Anderson, Richard A., et al.. (2007). Environmental toxicant-induced germ cell apoptosis in the human fetal testis. Human Reproduction. 22(11). 2912–2918. 46 indexed citations

18.

Anderson, Richard A., et al.. (2007). Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis. BMC Developmental Biology. 7(1). 136–136. 189 indexed citations

19.

Bayne, Rosemary A. L., et al.. (2006). Direct Effect of Progestogen on Gene Expression in the Testis during Gonadotropin Withdrawal and Early Suppression of Spermatogenesis. The Journal of Clinical Endocrinology & Metabolism. 91(7). 2526–2533. 21 indexed citations

20.

Anderson, Richard A., et al.. (2003). Evidence for Tissue Selectivity of the Synthetic Androgen 7α-Methyl-19-Nortestosterone in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism. 88(6). 2784–2793. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact